Source-Cell Storage Systems for Allogeneic Cell Therapy Products: Comparison of the Regulatory Systems in Target Countries
Research in Clinical Pharmacy · 2023
DOI: 10.59931/rcp.23.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Research in Clinical Pharmacy, 2023. Verfasst von Chanjoo Khan und 2 weiteren Autor:innen. Die Arbeit nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BYNC 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Science and ICT, Ministry of Education.
Abstract (Originalsprache)
Background
This study aimed to analyze autologous and allogeneic cell therapies.A gap analysis of source-cell storage regulations and guidelines of allogeneic cell therapies was performed for regulatory authorities in target countries, including the USA, EU, Japan, and Korea.
Methods
Cell-storage regulations and guidelines regarding allogeneic cell therapy products framed by regulatory authorities were comparatively analyzed.
Results
Of 41 cell therapies, 10 allogeneic cell therapies were selected, and their source cells were categorized based on 3 types of cell storage, namely cell bank (n=6) in the USA, Japan, and Korea; cell stock (n=2) in the EU; and drug substance (n=2) in Korea.In the gap analysis of cell storage regulations and guidelines by the selected regulatory authorities, cell storage systems have regulations and guidelines similar to those stipulated by regulatory authorities, except for the regulation of source-cell changes.Most allogeneic cell therapies used cell banks for cell storage.Thus, to ensure the safety of allogeneic cell therapy, more detailed criteria must be established for source-cell changes in cell storage systems.
Conclusion
Regulatory authorities can ensure a safer and more effective supply of therapy products to the public by harmonizing the regulations associated with allogeneic cell therapies.
Förderung
- National Research Foundation of Korea
- Ministry of Science and ICT
- Ministry of Education
Zitieren
APA
Khan, C., Shin, H., & Kim, E. (2023). Source-Cell Storage Systems for Allogeneic Cell Therapy Products: Comparison of the Regulatory Systems in Target Countries. Research in Clinical Pharmacy. https://doi.org/10.59931/rcp.23.006
Vancouver
Khan C, Shin H, Kim E. Source-Cell Storage Systems for Allogeneic Cell Therapy Products: Comparison of the Regulatory Systems in Target Countries. Research in Clinical Pharmacy. 2023. doi:10.59931/rcp.23.006
BibTeX
@article{Khan2023,
author = {Khan, Chanjoo and Shin, Hocheol and Kim, Eunyoung},
title = {Source-Cell Storage Systems for Allogeneic Cell Therapy Products: Comparison of the Regulatory Systems in Target Countries},
journal = {Research in Clinical Pharmacy},
year = {2023},
doi = {10.59931/rcp.23.006}
}
EUVIMED